Rayaz Ahmed Malik graduated in Medicine from the University of Aberdeen in 1991, obtained his MRCP (London) in 1996, PhD from the University of Manchester in 1997 and became a fellow of the Royal College of Physicians in 2007. He remains an honorary Professor of Medicine at the University of Manchester and visiting Professor of Medicine at Manchester Metropolitan University. He was appointed as the Organizational Official in November 2016 and as the Assistant Dean for Clinical Research at Weill Cornell Medicine-Qatar in February 2019.

His research focuses on the assessment and treatment of diabetes, obesity, peripheral neuropathies and central neurodegenerative diseases. Over ~20 years he has pioneered the use of corneal confocal microscopy, a non-invasive ophthalmic instrument, to quantify neurodegeneration in multiple peripheral neuropathies and in patients with Multiple Sclerosis, Parkinson’s disease, Stroke, Dementia, Autism and long-COVID.

Based on an independent Expertscape analysis, in 2022 he was ranked the 2nd and 7th most influential researcher on diabetes complications in the UK and the world, respectively. In 2023 Research.com ranked him as the number 1 researcher in Medicine in Qatar.